| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 02/21/2002 | CA2418273A1 Urea compounds and methods of uses |
| 02/21/2002 | CA2418266A1 Novel mitogen activated kinase |
| 02/21/2002 | CA2417846A1 2-aminopyridine compounds and medical use thereof |
| 02/21/2002 | CA2387002A1 Non-covalent inhibitors of urokinase and blood vessel formation |
| 02/20/2002 | EP1180518A1 5-pyridyl-1,3-azole compounds, process for producing the same and use thereof |
| 02/20/2002 | EP1180148A1 A VARIANT OF C6 BETA-CHEMOKINE LEUKOTACTIN-1(shLkn-1) WITH ENHANCED BIOLOGICAL ACTIVITY |
| 02/20/2002 | EP1180144A2 Cytoskeleton-associated proteins |
| 02/20/2002 | EP1180105A2 Substituted aza-oxindole derivatives |
| 02/20/2002 | EP1180099A1 New compounds |
| 02/20/2002 | EP1180098A1 New compounds |
| 02/20/2002 | EP1180028A1 Il-8 receptor antagonists |
| 02/20/2002 | EP1180025A1 Il-8 receptor antagonists |
| 02/20/2002 | EP0667904B1 Suppressor and progenitor cells |
| 02/20/2002 | CN1336917A Amide compounds |
| 02/20/2002 | CN1336200A Oral Chinese medicine for treating abiduria |
| 02/20/2002 | CN1336178A Prepn. of blood coagulation factor IX compound |
| 02/20/2002 | CN1079397C 4-(benzo-1,3-dioxolyl)-pyrrolidine-3-carboxylic acid derivatives as endothelin antagonists |
| 02/20/2002 | CN1079396C Aromatic amidine derivatives useful as selective thrombin inhibitors |
| 02/19/2002 | US6348602 Cyclic AMP-specific phosphodiesterase inhibitors |
| 02/19/2002 | US6348472 NPY antagonists: spiroisoquinolinone derivatives |
| 02/19/2002 | US6348444 Human growth hormone to stimulate hematopoiesis and immune reconstitution after hematopoietic stem cell transplantation in humans |
| 02/19/2002 | CA2126135C Use of human protein c for prevention and treatment of depositions of thrombocytes |
| 02/19/2002 | CA2085953C Human antithrombin-iii preparation |
| 02/19/2002 | CA2023246C Mutants of human interleukin-3 |
| 02/14/2002 | WO2002012340A2 Transporters and ion channels |
| 02/14/2002 | WO2002012326A2 Mechanism of conditional regulation of the hypoxia-inducible factor-1 by the von hippel-lindau tumor suppressor protein |
| 02/14/2002 | WO2002012245A2 Azabicyclic derivatives and their therapeutic use |
| 02/14/2002 | WO2002012239A1 Benzimidazole derivatives, preparation and therapeutic use thereof |
| 02/14/2002 | WO2002012235A1 1,4-dihydropyridines as bradykinin antagonists |
| 02/14/2002 | WO2002012210A1 Biphenyl derivatives and their use as ppar-gamma receptor activators |
| 02/14/2002 | WO2002012207A1 Cyclic oxyguanidine protease inhibitors |
| 02/14/2002 | WO2002012196A2 Lactam compounds and their use as inhibitors of serine proteases and method |
| 02/14/2002 | WO2002012178A1 Compounds acting as melanocortin receptor ligands |
| 02/14/2002 | WO2002012168A1 Novel n-(2-phenyl-3-aminopropyl)naphtamides |
| 02/14/2002 | WO2002011742A2 Methods for preventing reovirus recognition for the treatment of cellular proliferative disorders |
| 02/14/2002 | WO2002011740A2 'slow release' pharmaceutical compositions comprising lithium carbonate |
| 02/14/2002 | WO2002011735A2 Association of a purine activity and a nonsteroidal anti-inflammatory anti-inflammatory drug for treating sexual dysfunction |
| 02/14/2002 | WO2002011721A1 Pharmaceutical composition comprising metformin and a 5-phenoxyalkyl-2,4-thiazolidinedione-type derivative |
| 02/14/2002 | WO2002011715A2 The use of benzylideneaminoguanidines and hydroxyguanidines as melanocortin receptor ligands |
| 02/14/2002 | WO2002011710A2 Pharmaceutical compositions of cholesteryl ester transfer protein inhibitors |
| 02/14/2002 | WO2002011676A2 Method of using diketopiperazines and composition containing them |
| 02/14/2002 | WO2002011665A2 Association of a purine and a nonsteroidal anti-inflammatory drug for treating sexual dysfunction |
| 02/14/2002 | WO2001081415A9 Parathyroid hormone and parathyroid hormone-related protein antagonists |
| 02/14/2002 | WO2001072328A3 Methods of treating diseases with activated protein c |
| 02/14/2002 | WO2001057210A3 Use of dendroaspin as a vehicle for non-dendroaspin domains |
| 02/14/2002 | WO2001057021A3 2-[1H]-QUINOLONE AND 2-[1H]-QUINOXALONE INHIBITORS OF FACTOR Xa |
| 02/14/2002 | WO2001056598A3 Methods for preventing or attenuating pathoangiogenic conditions by using gbs-toxin (cm101) |
| 02/14/2002 | WO2001049685A3 Sulfonamides and derivatives thereof that modulate the activity of endothelin |
| 02/14/2002 | WO2001042288A3 G-protein coupled receptors |
| 02/14/2002 | WO2001032695A3 MODULATION OF eNOS ACTIVITY AND THERAPEUTIC USES THEREOF |
| 02/14/2002 | WO2001030802A3 Therapeutic treatments comprising administration of certain steroids for blood cell deficiencies |
| 02/14/2002 | WO2000043395A8 Substituted porphyrins |
| 02/14/2002 | WO2000009552A9 Secreted proteins and polynucleotides encoding them |
| 02/14/2002 | US20020019563 A S-(2-(1-iminoethyl)amino)ethyl)-2-methyl-L-cysteine |
| 02/14/2002 | US20020019534 Gem substituted hydroxamic acids |
| 02/14/2002 | US20020019533 Piperidine derivatives and anti-platelet agents containing the same |
| 02/14/2002 | US20020019395 Indalone and benzimidazolone inhibitors of factor Xa |
| 02/14/2002 | US20020019394 Bicyclic sulfonyl amino inhibitors of factor Xa |
| 02/14/2002 | US20020019393 Treating inflammation, autoimmune diseases, destructive bone disorders, proliferative disorders, infections, neurvous system disorders, reperfusion/ischemia in stroke, cardiovascular disorders, hypoxia, edema, fever, pain |
| 02/14/2002 | US20020019371 Use as anticoagulants; competitive inhibitors of thrombin; for example, 1-(phenyl-2-hydroxyethane-1,1-diylcarbonyl), 2-((4-amidinophenyl)- alkylaminocarbonyl)azetidine |
| 02/14/2002 | US20020019367 Compositions and methods for modulation of vascular structure and/or function |
| 02/14/2002 | US20020019043 Treating inflammatory bowel disease in humans; obtain human, administer drug, monitor for reduction in side effects from gastrointestinal disorder |
| 02/14/2002 | US20020018807 Mixture of cocoa plant extract and antichloesterol agent |
| 02/14/2002 | US20020018804 Biological bioadhesive composition and methods of preparation and use |
| 02/14/2002 | US20020018787 Synergistic mixture of dimethylglycine and mussel extract |
| 02/14/2002 | CA2774959A1 Method of using diketopiperazines and composition containing them |
| 02/14/2002 | CA2420066A1 Use, in combination, of a purine activity and a nonsteroidal anti-inflammatory drug for preparing an anti-thrombotic and/or anti-inflammatory drug |
| 02/14/2002 | CA2419042A1 Medicine for fighting against sexual dysfunction |
| 02/14/2002 | CA2418995A1 Lactam compounds and their use as inhibitors of serine proteases and method |
| 02/14/2002 | CA2418895A1 Biphenyl derivatives and their use as ppar-gamma receptor activators |
| 02/14/2002 | CA2418386A1 Mechanism of conditional regulation of the hypoxia-inducible factor-1 by the von hippel-lindau tumor suppressor protein |
| 02/14/2002 | CA2417967A1 Azabicyclic derivatives and their therapeutic use |
| 02/14/2002 | CA2417930A1 Pharmaceutical compositions containing lithium carbonate |
| 02/14/2002 | CA2417914A1 Cyclic oxyguanidine protease inhibitors |
| 02/14/2002 | CA2417883A1 Pharmaceutical composition comprising metformin and a 5-phenoxyalkyl-2,4-thiazolidinedione-type derivative |
| 02/14/2002 | CA2417755A1 Pharmaceutical compositions of cholesteryl ester transfer protein inhibitors |
| 02/14/2002 | CA2417587A1 Transporters and ion channels |
| 02/14/2002 | CA2417098A1 The use of benzylideneaminoguanidines and hydroxyguanidines as melanocortin receptor ligands |
| 02/14/2002 | CA2415467A1 Novel n-(2-phenyl-3-aminopropyl)naphtamides |
| 02/14/2002 | CA2412368A1 Benzimidazole derivatives, preparation and therapeutic use thereof |
| 02/13/2002 | EP1179539A1 Novel protein having hemolytic activity and gene encoding the protein |
| 02/13/2002 | EP1179353A1 Antithrombogenic implants with coating of polyphosphazenes and a pharmacologically active agent |
| 02/13/2002 | EP1179350A2 Encapsulated cell system for implantation into the human CNS |
| 02/13/2002 | EP1179065A2 Full-length molecules expressed in human tissues |
| 02/13/2002 | EP1179064A2 Secreted polypeptides and corresponding polynucleotides |
| 02/13/2002 | EP1179005A1 Steroid compounds with a c17-alkyl side chain and an aromatic a-ring for use in therapy |
| 02/13/2002 | EP1178986A2 Furanone derivatives as inhibitors of cathepsin s |
| 02/13/2002 | EP1178981A1 Substituted 3-pyridyl-4-arylpyrroles, and related therapeutic and prophylactic methods |
| 02/13/2002 | EP1178977A1 Ion channel modulating agents |
| 02/13/2002 | EP1178971A1 Substituted polycyclic aryl and heteroaryl uracils as anticoagulative agents |
| 02/13/2002 | EP1178970A1 Substituted polycyclic aryl and heteroaryl pyrymidinones useful as anticoagulants |
| 02/13/2002 | EP1178964A1 Substituted polycyclic aryl and heteroaryl pyridones useful for selective inhibition of the coagulation cascade |
| 02/13/2002 | EP1178959A1 Alpha-amino-beta-sulfonyl hydroxamic acid compounds |
| 02/13/2002 | EP1178817A2 Molecular interactions in haematopoietic cells |
| 02/13/2002 | EP1178809A1 Pharmaceutical composition in unit form containing acetylsalcylic acid and clopidogrel hydrogenosulphate |
| 02/13/2002 | EP1178790A1 Treatment to lower platelet adhesiveness |
| 02/13/2002 | EP0946561B1 Triazolo(4,5-d)pyrimidinyl derivatives and their use as medicaments |
| 02/13/2002 | EP0693925B1 Production of a recombinant factor xa inhibitor of leech hirudo medicinalis |
| 02/13/2002 | CN1335888A OPG fusion protein compositions and methods |
| 02/13/2002 | CN1335881A UME extract having medicinal effects and compositions containing the same |